Ikena Oncology, Inc.(IKNA)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

IKNA Ikena Oncology, Inc.

盘前交易 12-15 07:05:54 EST

1.43

+0.00

0.00%

最高1.43	最低1.43	成交量0.00
今开1.43	昨收1.43	日振幅0.00%
总市值6,901万	流通市值4,759万	总股本4,826万
成交额0.00	换手率0.00%	流通股本3,328万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"IKNA","market":"US","secType":"STK","nameCN":"Ikena Oncology, Inc.","latestPrice":1.43,"timestamp":1765573200000,"preClose":1.43,"halted":8,"volume":0,"delay":0,"floatShares":33282198,"shares":48258500,"eps":0,"marketStatus":"盘前交易","change":0,"latestTime":"12-15 07:05:54 EST","open":1.43,"high":1.43,"low":1.43,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":0,"tradingStatus":1,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1765809000000},"marketStatusCode":1,"symbolChange":{"newSymbol":"IMA","executeDate":"2025-07-28"},"adr":0,"listingDate":1616731200000,"exchange":"NASDAQ","adjPreClose":1.43,"volumeRatio":0.6720268914203383},"requestUrl":"/m/hq/s/IKNA/wiki","defaultTab":"wiki","newsList":[{"id":"2555703364","title":"创响生物宣布完成与Ikena Oncology反向并购交易","url":"https://stock-news.laohu8.com/highlight/detail?id=2555703364","media":"界面","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2555703364?lang=zh_cn&edition=full","pubTime":"2025-07-28 19:18","pubTimestamp":1753701497,"startTime":"0","endTime":"0","summary":"7月28日，创响生物宣布完成与Ikena Oncology, Inc.的反向并购交易。合并后的公司正式更名为ImageneBio,Inc.，并于2025年7月28日在美国纳斯达克挂牌，股票代码为“IMA”。Imagene的核心资产为OX40靶向单克隆抗体IMG-007，目前正在开展用于中重度特应性皮炎的2b期临床试验。伴随此次战略升级，Miragene亦宣布全面独立运营。除IMG-007以外，原Inmagene旗下的全部产品管线、合作项目及“智慧创新”平台资源将整体转移至Miragene。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025072819181797231671&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025072819181797231671&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IKNA","BK4007","BK4539","IMA"],"gpt_icon":0},{"id":"2551199839","title":"Ikena Oncology, Inc.盘中异动 股价大涨5.47%","url":"https://stock-news.laohu8.com/highlight/detail?id=2551199839","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2551199839?lang=zh_cn&edition=full","pubTime":"2025-07-16 00:32","pubTimestamp":1752597179,"startTime":"0","endTime":"0","summary":"北京时间2025年07月16日00时32分，Ikena Oncology, Inc.股票出现异动，股价快速拉升5.47%。Ikena Oncology, Inc.股票所在的生物技术行业中，整体跌幅为1.07%。Ikena Oncology, Inc.公司简介：Ikena Oncology Inc 是一家靶向肿瘤公司，为有需要的患者开发精准疗法，针对 Hippo 和 RAS 肿瘤信号网络中的癌症生长、扩散和治疗耐药节点。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025071600325997a7457d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025071600325997a7457d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","IKNA","BK4007"],"gpt_icon":0},{"id":"2549529277","title":"Ikena Oncology, Inc.盘中异动 临近午盘大幅拉升5.19%报1.42美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2549529277","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2549529277?lang=zh_cn&edition=full","pubTime":"2025-07-08 23:31","pubTimestamp":1751988677,"startTime":"0","endTime":"0","summary":"北京时间2025年07月08日23时31分，Ikena Oncology, Inc.股票出现异动，股价大幅上涨5.19%。截至发稿，该股报1.42美元/股，成交量6681股，换手率0.01%，振幅4.82%。Ikena Oncology, Inc.股票所在的生物技术行业中，整体涨幅为1.05%。Ikena Oncology, Inc.公司简介：Ikena Oncology Inc 是一家靶向肿瘤公司，为有需要的患者开发精准疗法，针对 Hippo 和 RAS 肿瘤信号网络中的癌症生长、扩散和治疗耐药节点。其其他候选产品是 IK-175 和 IK-595。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250708233117a43e5e7c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250708233117a43e5e7c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","BK4007","IKNA"],"gpt_icon":0},{"id":"2544044396","title":"Ikena Oncology, Inc.盘中异动 股价大涨6.67%","url":"https://stock-news.laohu8.com/highlight/detail?id=2544044396","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2544044396?lang=zh_cn&edition=full","pubTime":"2025-06-17 00:37","pubTimestamp":1750091842,"startTime":"0","endTime":"0","summary":"北京时间2025年06月17日00时37分，Ikena Oncology, Inc.股票出现波动，股价快速拉升6.67%。Ikena Oncology, Inc.股票所在的生物技术行业中，整体跌幅为0.54%。Ikena Oncology, Inc.公司简介：Ikena Oncology Inc 是一家靶向肿瘤公司，为有需要的患者开发精准疗法，针对 Hippo 和 RAS 肿瘤信号网络中的癌症生长、扩散和治疗耐药节点。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250617003723951eec61&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250617003723951eec61&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IKNA","BK4539","BK4007"],"gpt_icon":0},{"id":"2517164592","title":"Ikena Oncology, Inc.盘中异动 早盘急速上涨5.93%报1.43美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2517164592","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517164592?lang=zh_cn&edition=full","pubTime":"2025-03-06 23:09","pubTimestamp":1741273769,"startTime":"0","endTime":"0","summary":"北京时间2025年03月06日23时09分，Ikena Oncology, Inc.股票出现波动，股价急速拉升5.93%。截至发稿，该股报1.43美元/股，成交量5.679万股，换手率0.12%，振幅3.33%。Ikena Oncology, Inc.股票所在的生物技术行业中，整体跌幅为0.44%。Ikena Oncology, Inc.公司简介：Ikena Oncology Inc 是一家靶向肿瘤公司，为有需要的患者开发精准疗法，针对 Hippo 和 RAS 肿瘤信号网络中的癌症生长、扩散和治疗耐药节点。其其他候选产品是 IK-175 和 IK-595。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306230929989ebc8b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306230929989ebc8b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","BK4007","IKNA"],"gpt_icon":0},{"id":"2517983455","title":"Ikena Oncology, Inc.盘中异动 下午盘快速上涨5.43%","url":"https://stock-news.laohu8.com/highlight/detail?id=2517983455","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517983455?lang=zh_cn&edition=full","pubTime":"2025-03-05 04:02","pubTimestamp":1741118528,"startTime":"0","endTime":"0","summary":"北京时间2025年03月05日04时02分，Ikena Oncology, Inc.股票出现波动，股价快速上涨5.43%。Ikena Oncology, Inc.股票所在的生物技术行业中，整体涨幅为0.13%。Ikena Oncology, Inc.公司简介：Ikena Oncology Inc 是一家靶向肿瘤公司，为有需要的患者开发精准疗法，针对 Hippo 和 RAS 肿瘤信号网络中的癌症生长、扩散和治疗耐药节点。其其他候选产品是 IK-175 和 IK-595。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305040209abe84c9c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305040209abe84c9c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","IKNA","BK4539"],"gpt_icon":0},{"id":"2516587776","title":"Ikena Oncology, Inc.盘中异动 股价大跌5.22%报1.27美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2516587776","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516587776?lang=zh_cn&edition=full","pubTime":"2025-03-03 23:56","pubTimestamp":1741017404,"startTime":"0","endTime":"0","summary":"北京时间2025年03月03日23时56分，Ikena Oncology, Inc.股票出现异动，股价快速下挫5.22%。截至发稿，该股报1.27美元/股，成交量2.6312万股，换手率0.05%，振幅3.73%。Ikena Oncology, Inc.股票所在的生物技术行业中，整体跌幅为0.38%。Ikena Oncology, Inc.公司简介：Ikena Oncology Inc 是一家靶向肿瘤公司，为有需要的患者开发精准疗法，针对 Hippo 和 RAS 肿瘤信号网络中的癌症生长、扩散和治疗耐药节点。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250303235644a25d5b25&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250303235644a25d5b25&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IKNA","BK4007","BK4539"],"gpt_icon":0},{"id":"2516760543","title":"Ikena Oncology, Inc.盘中异动 早盘快速跳水5.11%","url":"https://stock-news.laohu8.com/highlight/detail?id=2516760543","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516760543?lang=zh_cn&edition=full","pubTime":"2025-02-28 23:54","pubTimestamp":1740758088,"startTime":"0","endTime":"0","summary":"北京时间2025年02月28日23时54分，Ikena Oncology, Inc.股票出现波动，股价快速下跌5.11%。Ikena Oncology, Inc.股票所在的生物技术行业中，整体涨幅为0.14%。Ikena Oncology, Inc.公司简介：Ikena Oncology Inc 是一家靶向肿瘤公司，为有需要的患者开发精准疗法，针对 Hippo 和 RAS 肿瘤信号网络中的癌症生长、扩散和治疗耐药节点。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250228235448a2581686&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250228235448a2581686&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IKNA","BK4007","BK4539"],"gpt_icon":0},{"id":"2511576385","title":"Ikena Oncology, Inc.盘中异动 下午盘快速拉升5.48%","url":"https://stock-news.laohu8.com/highlight/detail?id=2511576385","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2511576385?lang=zh_cn&edition=full","pubTime":"2025-02-14 02:31","pubTimestamp":1739471496,"startTime":"0","endTime":"0","summary":"北京时间2025年02月14日02时31分，Ikena Oncology, Inc.股票出现波动，股价快速拉升5.48%。Ikena Oncology, Inc.股票所在的生物技术行业中，整体涨幅为0.79%。Ikena Oncology, Inc.公司简介：Ikena Oncology Inc 是一家靶向肿瘤公司，为有需要的患者开发精准疗法，针对 Hippo 和 RAS 肿瘤信号网络中的癌症生长、扩散和治疗耐药节点。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250214023137a244db33&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250214023137a244db33&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","IKNA","BK4539"],"gpt_icon":0},{"id":"2508331124","title":"Ikena Oncology, Inc.盘中异动 快速下跌5.30%","url":"https://stock-news.laohu8.com/highlight/detail?id=2508331124","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2508331124?lang=zh_cn&edition=full","pubTime":"2025-02-04 02:47","pubTimestamp":1738608457,"startTime":"0","endTime":"0","summary":"北京时间2025年02月04日02时47分，Ikena Oncology, Inc.股票出现异动，股价大幅跳水5.30%。Ikena Oncology, Inc.股票所在的生物技术行业中，整体跌幅为0.29%。Ikena Oncology, Inc.公司简介：Ikena Oncology Inc 是一家靶向肿瘤公司，为有需要的患者开发精准疗法，针对 Hippo 和 RAS 肿瘤信号网络中的癌症生长、扩散和治疗耐药节点。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250204024738abc13a15&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250204024738abc13a15&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IKNA","BK4539","BK4007"],"gpt_icon":0},{"id":"2503091375","title":"Ikena Oncology, Inc.盘中异动 急速下跌5.19%报1.46美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2503091375","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2503091375?lang=zh_cn&edition=full","pubTime":"2025-01-15 01:10","pubTimestamp":1736874604,"startTime":"0","endTime":"0","summary":"北京时间2025年01月15日01时10分，Ikena Oncology, Inc.股票出现波动，股价急速跳水5.19%。Ikena Oncology, Inc.股票所在的生物技术行业中，整体跌幅为0.62%。Ikena Oncology, Inc.公司简介：Ikena Oncology Inc 是一家靶向肿瘤公司，为有需要的患者开发精准疗法，针对 Hippo 和 RAS 肿瘤信号网络中的癌症生长、扩散和治疗耐药节点。其其他候选产品是 IK-175 和 IK-595。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250115011005a221daba&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250115011005a221daba&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IKNA","BK4539","BK4007"],"gpt_icon":0},{"id":"2503309586","title":"Ikena Oncology, Inc.盘中异动 早盘股价大跌5.13%报1.48美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2503309586","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2503309586?lang=zh_cn&edition=full","pubTime":"2025-01-13 23:00","pubTimestamp":1736780424,"startTime":"0","endTime":"0","summary":"北京时间2025年01月13日23时00分，Ikena Oncology, Inc.股票出现波动，股价快速下跌5.13%。截至发稿，该股报1.48美元/股，成交量4.7972万股，换手率0.10%，振幅4.49%。Ikena Oncology, Inc.股票所在的生物技术行业中，整体跌幅为1.35%。Ikena Oncology, Inc.公司简介：Ikena Oncology Inc 是一家靶向肿瘤公司，为有需要的患者开发精准疗法，针对 Hippo 和 RAS 肿瘤信号网络中的癌症生长、扩散和治疗耐药节点。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250113230024960258d4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250113230024960258d4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","BK4539","IKNA"],"gpt_icon":0},{"id":"2495579984","title":"Ikena Oncology, Inc.盘中异动 股价大涨5.19%","url":"https://stock-news.laohu8.com/highlight/detail?id=2495579984","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2495579984?lang=zh_cn&edition=full","pubTime":"2024-12-31 02:23","pubTimestamp":1735583026,"startTime":"0","endTime":"0","summary":"北京时间2024年12月31日02时23分，Ikena Oncology, Inc.股票出现波动，股价急速上涨5.19%。Ikena Oncology, Inc.股票所在的生物技术行业中，整体跌幅为1.02%。Ikena Oncology, Inc.公司简介：Ikena Oncology Inc 是一家靶向肿瘤公司，为有需要的患者开发精准疗法，针对 Hippo 和 RAS 肿瘤信号网络中的癌症生长、扩散和治疗耐药节点。其其他候选产品是 IK-175 和 IK-595。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241231022346ab9855ab&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241231022346ab9855ab&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IKNA","BK4007","BK4539"],"gpt_icon":0},{"id":"2494018455","title":"创响生物与Ikena Oncology合并，融资7500万美元 ，OX40 单克隆抗体能否撑起未来？","url":"https://stock-news.laohu8.com/highlight/detail?id=2494018455","media":"市场资讯","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2494018455?lang=zh_cn&edition=full","pubTime":"2024-12-25 14:01","pubTimestamp":1735106460,"startTime":"0","endTime":"0","summary":"合并后的公司将专注于开发针对OX40的单克隆抗体IMG-007，用于治疗特应性皮炎。IMG-007是一种具有Fc调节功能并沉默ADCC的OX40抗体，旨在最小化潜在的安全风险。结论单次剂量高达600 mg的IMG-007在健康参与者中耐受良好，并在高剂量下表现出延长的半衰期。IMG-007，作为一种非消耗性抗 OX40 单克隆抗体，通过抗体工程设计延长了半衰期，同时沉默了ADCC功能，与协和麒麟的Rocatinlimab设计正好相反。从疗效方面，也是OX40L抗体amlitelimab更优。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241225145326a208a5e9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241225145326a208a5e9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4161","BK4007","IKNA","LD","BK4539","AE","PK","CVR","BK4218","BK4181","BK4138"],"gpt_icon":0},{"id":"2494068201","title":"创响生物与Ikena Oncology达成合并协议，完成7500万美元融资","url":"https://stock-news.laohu8.com/highlight/detail?id=2494068201","media":"界面","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2494068201?lang=zh_cn&edition=full","pubTime":"2024-12-25 07:40","pubTimestamp":1735083652,"startTime":"0","endTime":"0","summary":"当地时间12月23日，创响生物（Inmagene）在官网宣布已与Ikena Oncology（Nasdaq: IKNA）达成最终合并协议。此次交易预计将带来约1.75亿美元（包括7500万美元的超额认购私募融资），用于合并后的公司进一步开发针对OX40的单克隆抗体IMG-007，用于治疗特应性皮炎。合并后的公司计划以“ImageneBio, Inc.”的名称运营，并在纳斯达克以“IMA”的股票代码进行交易。该交易预计将于2025年年中完成。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241225074057a20832cf&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241225074057a20832cf&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","BK4007","IKNA"],"gpt_icon":0},{"id":"2493087288","title":"Ikena Oncology, Inc.盘中异动 快速下跌7.19%","url":"https://stock-news.laohu8.com/highlight/detail?id=2493087288","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2493087288?lang=zh_cn&edition=full","pubTime":"2024-12-24 22:40","pubTimestamp":1735051258,"startTime":"0","endTime":"0","summary":"北京时间2024年12月24日22时40分，Ikena Oncology, Inc.股票出现波动，股价急速下跌7.19%。Ikena Oncology, Inc.股票所在的生物技术行业中，整体跌幅为0.45%。Ikena Oncology, Inc.公司简介：Ikena Oncology Inc 是一家靶向肿瘤公司，为有需要的患者开发精准疗法，针对 Hippo 和 RAS 肿瘤信号网络中的癌症生长、扩散和治疗耐药节点。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241224224059a207c2c5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241224224059a207c2c5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","IKNA","BK4007"],"gpt_icon":0},{"id":"2493761341","title":"Ikena Oncology, Inc.股价拉升22.58% 市值涨2070.36万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2493761341","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2493761341?lang=zh_cn&edition=full","pubTime":"2024-12-23 22:35","pubTimestamp":1734964540,"startTime":"0","endTime":"0","summary":"北京时间2024年12月23日22时35分，Ikena Oncology, Inc.股票出现波动，股价急速上涨22.58%。Ikena Oncology, Inc.股票所在的生物技术行业中，整体涨幅为0.14%。Ikena Oncology, Inc.公司简介：Ikena Oncology Inc 是一家靶向肿瘤公司，为有需要的患者开发精准疗法，针对 Hippo 和 RAS 肿瘤信号网络中的癌症生长、扩散和治疗耐药节点。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241223223540ab8e4224&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241223223540ab8e4224&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","BK4539","IKNA"],"gpt_icon":0},{"id":"2492104159","title":"Ikena Oncology, Inc.盘中异动 股价大跌6.17%","url":"https://stock-news.laohu8.com/highlight/detail?id=2492104159","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492104159?lang=zh_cn&edition=full","pubTime":"2024-12-19 04:36","pubTimestamp":1734554212,"startTime":"0","endTime":"0","summary":"北京时间2024年12月19日04时36分，Ikena Oncology, Inc.股票出现异动，股价急速跳水6.17%。Ikena Oncology, Inc.股票所在的生物技术行业中，整体跌幅为2.57%。Ikena Oncology, Inc.公司简介：Ikena Oncology Inc 是一家靶向肿瘤公司，为有需要的患者开发精准疗法，针对 Hippo 和 RAS 肿瘤信号网络中的癌症生长、扩散和治疗耐药节点。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241219043653a1f9574c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241219043653a1f9574c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","IKNA","BK4007"],"gpt_icon":0},{"id":"2492473076","title":"Ikena Oncology, Inc.盘中异动 股价大跌5.45%报1.56美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2492473076","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492473076?lang=zh_cn&edition=full","pubTime":"2024-12-17 04:35","pubTimestamp":1734381331,"startTime":"0","endTime":"0","summary":"北京时间2024年12月17日04时35分，Ikena Oncology, Inc.股票出现异动，股价大幅下挫5.45%。截至发稿，该股报1.56美元/股，成交量11.6981万股，换手率0.24%，振幅5.15%。Ikena Oncology, Inc.股票所在的生物技术行业中，整体涨幅为0.17%。Ikena Oncology, Inc.公司简介：Ikena Oncology Inc 是一家靶向肿瘤公司，为有需要的患者开发精准疗法，针对 Hippo 和 RAS 肿瘤信号网络中的癌症生长、扩散和治疗耐药节点。其其他候选产品是 IK-175 和 IK-595。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241217043531a1f3dd4f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241217043531a1f3dd4f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IKNA","BK4539","BK4007"],"gpt_icon":0},{"id":"2483383305","title":"Ikena Oncology, Inc.2024财年第三财季实现净利润-10.23百万美元，同比增加41.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2483383305","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483383305?lang=zh_cn&edition=full","pubTime":"2024-11-14 00:00","pubTimestamp":1731513631,"startTime":"0","endTime":"0","summary":"11月14日，Ikena Oncology, Inc.公布财报，公告显示公司2024财年第三财季净利润为-10.23百万美元，同比增加41.00%；其中营业收入为0.00美元，每股基本收益为-0.21美元。从资产负债表来看，Ikena Oncology, Inc.总负债14.76百万美元，其中短期债务3.92百万美元，资产负债比为0.11，流动比率为0.16。机构评级：截至2024年11月14日，当前有2家机构对Ikena Oncology, Inc.目标价做出预测，其中目标均价为3.00美元，其中最低目标价为2.00美元，最高目标价为4.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241114000100abbe0dab&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241114000100abbe0dab&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IKNA"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.ikenaoncology.com","stockEarnings":[{"period":"1week","weight":-0.9167},{"period":"1month","weight":-0.9167},{"period":"3month","weight":-0.9167},{"period":"6month","weight":-0.9117},{"period":"1year","weight":-0.9282},{"period":"ytd","weight":-0.9273}],"compareEarnings":[{"period":"1week","weight":-0.0057},{"period":"1month","weight":-0.0024},{"period":"3month","weight":0.037},{"period":"6month","weight":0.142},{"period":"1year","weight":0.1281},{"period":"ytd","weight":0.1633}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Ikena Oncology, Inc.于2016年3月2日成立为特拉华州公司，总部位于马萨诸塞州波士顿。该公司是一家靶向肿瘤公司，专注于开发针对驱动癌症形成和扩散的关键信号通路的新型癌症疗法。该公司的项目专注于关键的癌症驱动途径，这些途径在科学文献中得到了很好的验证，但缺乏经批准或有效的治疗方法，因此有可能解决高度未满足的医疗需求。通过利用对发现化学、转化科学和以患者为中心的药物开发的深刻理解，该公司建立了一个专注于基因定义或生物标记物驱动的癌症的全资和合作项目的深入渠道，能够针对该公司认为最有可能的特定患者群体对候选产品的治疗作出反应。自2016年开始运营以来，该公司已经发现或开发了5个肿瘤项目，其中包括4个IND研究或临床开发的候选产品。","yearOnYearQuotes":[{"month":1,"riseRate":0.25,"avgChangeRate":-0.009984},{"month":2,"riseRate":0.25,"avgChangeRate":-0.11454},{"month":3,"riseRate":0,"avgChangeRate":-0.048264},{"month":4,"riseRate":0.2,"avgChangeRate":0.002486},{"month":5,"riseRate":0.6,"avgChangeRate":0.039135},{"month":6,"riseRate":0.6,"avgChangeRate":-0.001759},{"month":7,"riseRate":0.6,"avgChangeRate":-0.056308},{"month":8,"riseRate":0.5,"avgChangeRate":0.039063},{"month":9,"riseRate":0.25,"avgChangeRate":-0.081793},{"month":10,"riseRate":0,"avgChangeRate":-0.113594},{"month":11,"riseRate":0.5,"avgChangeRate":-0.121724},{"month":12,"riseRate":0.4,"avgChangeRate":-0.108125}],"exchange":"NASDAQ","name":"Ikena Oncology, Inc.","nameEN":"Ikena Oncology, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.35.12","shortVersion":"4.35.12","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Ikena Oncology, Inc.(IKNA)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Ikena Oncology, Inc.(IKNA)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Ikena Oncology, Inc.,IKNA,Ikena Oncology, Inc.股票,Ikena Oncology, Inc.股票老虎,Ikena Oncology, Inc.股票老虎国际,Ikena Oncology, Inc.行情,Ikena Oncology, Inc.股票行情,Ikena Oncology, Inc.股价,Ikena Oncology, Inc.股市,Ikena Oncology, Inc.股票价格,Ikena Oncology, Inc.股票交易,Ikena Oncology, Inc.股票购买,Ikena Oncology, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Ikena Oncology, Inc.(IKNA)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Ikena Oncology, Inc.(IKNA)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}